1.
Int J Clin Pharmacol Ther
; 47(1): 58-60, 2009 Jan.
Article
in English
| MEDLINE
| ID: mdl-19203540
Subject(s)
Antineoplastic Agents/pharmacokinetics , Indazoles/pharmacokinetics , Neoplasms/metabolism , Ruthenium Compounds/pharmacokinetics , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/chemistry , Antineoplastic Agents/therapeutic use , Biomarkers/blood , Biomarkers/chemistry , Clinical Trials, Phase I as Topic , Clinical Trials, Phase II as Topic , DNA Adducts/blood , DNA Adducts/chemistry , Dose-Response Relationship, Drug , Half-Life , Humans , Indazoles/administration & dosage , Indazoles/chemistry , Indazoles/therapeutic use , Infusions, Intravenous , Leukocytes/chemistry , Metabolic Clearance Rate , Neoplasms/drug therapy , Organometallic Compounds , Ruthenium Compounds/administration & dosage , Ruthenium Compounds/chemistry , Ruthenium Compounds/therapeutic use , Serum Albumin/analysis , Serum Albumin/chemistry , Serum Albumin/metabolism , Transferrin/analysis , Transferrin/chemistry , Transferrin/metabolism
2.
Int J Clin Pharmacol Ther
; 47(1): 61-4, 2009 Jan.
Article
in English
| MEDLINE
| ID: mdl-19203541
Subject(s)
Antineoplastic Agents/pharmacokinetics , Benzenesulfonates/pharmacokinetics , Kidney Diseases/therapy , Protein Kinase Inhibitors/pharmacokinetics , Pyridines/pharmacokinetics , Renal Dialysis , Antineoplastic Agents/metabolism , Antineoplastic Agents/therapeutic use , Benzenesulfonates/metabolism , Benzenesulfonates/therapeutic use , Blood Specimen Collection , Clinical Trials as Topic , Dose-Response Relationship, Drug , Drug Administration Schedule , Humans , Kidney Diseases/blood , Kidney Diseases/physiopathology , Niacinamide/analogs & derivatives , Phenylurea Compounds , Protein Kinase Inhibitors/metabolism , Protein Kinase Inhibitors/therapeutic use , Pyridines/chemistry , Pyridines/metabolism , Pyridines/therapeutic use , Sorafenib , Time Factors
3.
Int J Clin Pharmacol Ther
; 47(1): 65-7, 2009 Jan.
Article
in English
| MEDLINE
| ID: mdl-19203542
Subject(s)
Antimetabolites, Antineoplastic/therapeutic use , Oxonic Acid/pharmacokinetics , Oxonic Acid/therapeutic use , Tegafur/pharmacokinetics , Tegafur/therapeutic use , 2-Pyridinylmethylsulfinylbenzimidazoles/administration & dosage , Administration, Oral , Anti-Ulcer Agents/administration & dosage , Antimetabolites, Antineoplastic/blood , Antimetabolites, Antineoplastic/pharmacokinetics , Area Under Curve , Biological Availability , Clinical Trials as Topic , Dihydrouracil Dehydrogenase (NADP)/blood , Drug Combinations , Fasting , Fluorouracil/analogs & derivatives , Fluorouracil/metabolism , Food , Gastric Acidity Determination , Half-Life , Humans , Hydrogen-Ion Concentration , Oxonic Acid/blood , Oxonic Acid/metabolism , Pantoprazole , Pyridines/metabolism , Pyridines/pharmacokinetics , Pyridines/therapeutic use , Tegafur/blood , Tegafur/metabolism , Triazines/metabolism , Uracil/analogs & derivatives , Uracil/metabolism , beta-Alanine/analogs & derivatives , beta-Alanine/metabolism
4.
Int J Clin Pharmacol Ther
; 43(12): 586-7, 2005 Dec.
Article
in English
| MEDLINE
| ID: mdl-16372527
Subject(s)
Biopsy , Carcinoma , Neoplasms , Oxygen , Tissue Preservation , Cell Line, Tumor , Cell Survival , DNA, Neoplasm/analysis , Humans , Nanostructures , RNA, Neoplasm/analysis , Solutions , Temperature
5.
Int J Clin Pharmacol Ther
; 42(11): 659-60, 2004 Nov.
Article
in English
| MEDLINE
| ID: mdl-15598039
Subject(s)
Cell Culture Techniques , Cell Line, Tumor , Cell Survival , Humans , Solutions , Specimen Handling/methods
6.
Biochem Pharmacol
; 30(24): 3385-8, 1981 Dec 15.
Article
in English
| MEDLINE
| ID: mdl-6173042